| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2903376 | Chest | 2009 | 9 Pages |
Abstract
In our multicenter CAP cohort, MR-proADM levels correlate with increasing severity of illness and death. High MR-proADM levels offer additional risk stratification in high-risk CAP patients, but otherwise MR-proADM levels do not alter PSI-based risk assessment in most CAP patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David T. MD, MPH, Derek C. MD, MPH, FCCP, John A. MD, Nathan A. BS, Lisa A. PhD, Joachim PhD, Russell L. PhD, Matthew R. MD, MPH, Donald M. MD,